Apparent improvement of fatty liver by petite low carbohydrate diet (LCD) in patient with type 2 diabetes (T2D)

Bando H, Iwatsuki N, Okada M, Ogawa T and Sakamoto K

Published on: 2024-04-02

Abstract

The case is a 64-year-old female patient with type 2 diabetes (T2D), dyslipidemia, hypertension who has been taking the medicines Metformin, Linagliptin, Rosuvastatin, and Amlodipine. She continued the petite low carbohydrate diet (LCD) for the latest 2-3 years, and then clinical changes were found, including weight reduction of 3-4 kg, improvement of fatty liver by abdominal CT scan, and laboratory data of GOT 87 to 20 U/L, GPT 63 to 24 U/L, GGT 209 to 99 U/L, HbA1c 7.6 to 6.2%, and LDL 166 to 57 mg/dL. Though LCD is continued to a limited degree, it can contribute to the clinical improvement of T2D and metabolic dysfunction-associated steatotic liver disease (MASLD).